Skip to content

Metabolic effects of morning light in obesity and type 2 diabetes

Metabolic effects of morning light in obesity and type 2 diabetes - SUNRISE 2

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON38552
Enrollment
16
Registered
2013-12-16
Start date
2014-01-07
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Group 1 (n25 kg/m2 - habitual wake-up time between 6:00 and 9:00 - no DM2: fasting venous plasma glucose 25 kg/m2 - habitual wake-up time between 6:00 and 9:00 - type 2 diabetes: fasting venous plasma glucose >6.9 mmol/l or HbA1c > 6.5%

Exclusion criteria

Exclusion criteria: - use of any other medication than metformin that interferers with glucose metabolism or neuronal synaptic transmission (corticosteroids, anti-depressants, anti-epileptic medication, other psychotropic drugs, anti malarials) - gastro-intestinal or metabolic disease that will interfere with digestion or metabolism - neuropsychiatric illness including severe depression - epilepsy - hypertension - ophthalmological abnormalities (e.g. retinopathy) - lactose intolerance - soy allergy

Design outcomes

Primary

MeasureTime frame
Postprandial glucose excursions, and expression of metabolic genes in adipose tissue.

Secondary

MeasureTime frame
- postprandial insulin excursions - postprandial free fatty acid (FFA) excursions - postprandial triglyceride levels - morning glucocorticoid increase - morning salivary melatonin decrease - resting energy expenditure (REE) - measurements of autonomic balance: - skin temperature decrease - heart rate variability - hunger and satiety ratings - clock gene expression in leucocytes

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)